Evidence Synthesis
Wockhardt Pharma Sees Steady Growth in Gross Margin and Marginal Operating Leverage, with Revenue Growth Accelerating.
The company's gross margin accelerated to , up from 14.32%. Meanwhile, its marginal operating leverage increased to , up from 11.2%. Revenue growth also accelerated to , up from in the previous quarter.
In terms of trading activity, Wockhardt Pharma's daily volume decreased to , down from 1613650 shares in the previous day. The company's close price rose to , up from 1830.6 INR in the previous day.